Related references
Note: Only part of the references are listed.Aqueous flare is increased in patients with clinically significant cystoid macular oedema after cataract surgery
Lebriz Ersoy et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration
Philipp S. Muether et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2013)
Retreatment by series of three intravitreal injections of ranibizumab in neovascular age-related macular degeneration: long-term outcomes
Maher Saleh et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2013)
Improved Brilliant Blue G Staining of the Internal Limiting Membrane with Sharp Cut Filters of a Novel Viewing Filter System
Hiroshi Enaida et al.
OPHTHALMOLOGICA (2013)
Outcomes of cataract surgery in patients with neovascular age-related macular degeneration in the era of anti-vascular endothelial growth factor therapy
Homayoun Tabandeh et al.
JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2012)
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
Daniel F. Martin et al.
OPHTHALMOLOGY (2012)
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
Usha Chakravarthy et al.
OPHTHALMOLOGY (2012)
TIME TO FIRST TREATMENT The Significance of Early Treatment of Exudative Age-related Macular Degeneration
Renate Rauch et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)
Cataract Surgery in Ranibizumab-Treated Patients With Neovascular Age-Related Macular Degeneration From the Phase 3 ANCHOR and MARINA Trials
Philip J. Rosenfeld et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2011)
Phacoemulsification in eyes with neovascular AMD treated with anti-VEGF injections
Maria Muzyka-Wozniak
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2011)
Myositis Ossificans
Deborah A. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
Geeta A. Lalwani et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss
L. Arias et al.
EYE (2009)
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (lucentis) for neovascular age-related macular degeneration
Anne E. Fung et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration
Richard F. Spaide et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Progression of visual loss and time between initial assessment and treatment of wet age-related macular degeneration
M Oliver-Fernandez et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2005)
Share Paper
